Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL6283981 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL9014903 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL18162 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL41143 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL11840630 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL9011886 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL17142189 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL3666217 | 0.94 | SLC34A1 (0.50) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL19974227 | 0.94 | SLC34A1 (0.50) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL22462708 | 0.94 | SLC34A1 (0.50) | SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1239856-A | — | — | None | — | — | JP | disclosed |
| JP-7328104-A | — | — | None | — | — | JP | disclosed |
| EP-1306466-B1 | Electroless gold plating composition | ROHM & HAAS ELECT MAT (US) | 2018-11-21 | — | — | EP | disclosed |
| EP-2837690-B1 | METHOD FOR SIMULTANEOUS DETECTION, RECOVERY, IDENTIFICATION AND COUNTING OF MICROORGANISMS AND THREE DIMENTIOANL STRUCTURE FOR THE IMPLEMENTATION OF SAID METHOD | CENTRO NAC DE BIOPREPARADOS (BIOCEN) (CU) | 2017-09-13 | — | — | EP | disclosed |
| EP-2184277-B1 | ARYL PYRIMIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | INST PHARM & TOXICOLOGY AMMS (CN) | 2015-07-01 | — | — | EP | disclosed |
| US-20150148258-A1 | METHOD FOR SIMULTANEOUS DETECTION, RECOVERY, IDENTIFICATION AND COUNTING OF MICROORGANISMS AND DEVICES FOR THE IMPLEMENTATION OF SAID METHOD | CENTRO NACIONAL DE INVESTIGACIONES CIENTIFICAS (CNIC) (CU) | 2015-05-28 | — | — | US | disclosed |
| EP-2837690-A2 | METHOD FOR SIMULTANEOUS DETECTION, RECOVERY, IDENTIFICATION AND COUNTING OF MICROORGANISMS AND DEVICES FOR THE IMPLEMENTATION OF SAID METHOD | Centro Nacional de Biopreparados (Biocen) (CU) | 2015-02-18 | — | — | EP | disclosed |
| US-8759355-B2 | Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. (CN) | 2014-06-24 | — | — | US | disclosed |
| US-20110009427-A1 | ARYL PYRIMIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | INSTITUE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2011-01-13 | — | — | US | disclosed |
| EP-2184277-A1 | ARYL PYRIMIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China (CN) | 2010-05-12 | — | — | EP | disclosed |
| EP-1306466-A2 | Electroless gold plating composition | Shipley Co. L.L.C. (US) | 2003-05-02 | — | — | EP | disclosed |
| US-20030059799-A1 | Modified DNA molecule, recombinant containing the same, and uses thereof | ZEON CORPORATION (JP) | 2003-03-27 | — | — | US | disclosed |
| EP-1275716-A2 | Modified DNA molecule, recombinant containing the same thing, and uses thereof | Zeon Corporation (JP) | 2003-01-15 | — | — | EP | disclosed |
| JP-H07328104-A | DEODORANT | KONAN KAGAKU KOGYO KK | 1995-12-19 | — | — | JP | disclosed |
| CN-1028205-C | Application of dihydropyridine-3, 5-dihydroxy acid ester derivative | YAMANOUCHI PHARMA CO LTD (JP) | 1995-04-19 | — | — | CN | disclosed |
| EP-0200409-B1 | Moulded material comprising bacteria-produced cellulose | AGENCY IND SCIENCE TECHN (JP) | 1994-06-29 | — | — | EP | disclosed |
| JP-H01239856-A | GOLD PLATING OF ELECTRONIC COMPONENT OF SEMICONDUCTOR INTEGRATED CIRCUIT | YAMAGUCHI PREF GOV | 1989-09-25 | — | — | JP | disclosed |
| CN-1005152-B | Preparation method of dihydropyridine-3, 5-dicarboxylic ester derivative | 山之内制药株式会社 | 1989-09-13 | — | — | CN | disclosed |
| US-4742164-A | RIBBON-SHAPED MICROFIBRILS; COMPOSITE PLASTICS | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1988-05-03 | — | — | US | disclosed |
| EP-0200409-A2 | Moulded material comprising bacteria-produced cellulose | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1986-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009427-A1 | ARYL PYRIMIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | PPARD, PPARG, PPARA | SLC34A1 427/4885LMNA 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.